iTeos Therapeutics, Inc. - ITOS

About Gravity Analytica
Recent News
- 07.21.2025 - iTeos Therapeutics Enters into Agreement to Be Acquired by Concentra Biosciences for $10.047 in Cash per Share Plus a Contingent Value Right
- 07.21.2025 - iTeos Therapeutics Enters into Agreement to Be Acquired by Concentra Biosciences for $10.047 in Cash per Share Plus a Contingent Value Right
- 05.28.2025 - iTeos Therapeutics Announces Its Intention to Wind Down Operations
- 05.28.2025 - iTeos Therapeutics Announces Its Intention to Wind Down Operations
Recent Filings
- 06.17.2025 - 8-K Current report
- 06.12.2025 - SCHEDULE 13D General Statement of Acquisition of Beneficial Ownership
- 06.11.2025 - 4 Statement of changes in beneficial ownership of securities
- 06.10.2025 - 144 Report of proposed sale of securities
- 06.09.2025 - 144 Report of proposed sale of securities
- 06.06.2025 - 4 Statement of changes in beneficial ownership of securities
- 06.06.2025 - 144 Report of proposed sale of securities
- 06.06.2025 - 144 Report of proposed sale of securities
- 06.06.2025 - 4 Statement of changes in beneficial ownership of securities
- 06.05.2025 - 144 Report of proposed sale of securities